from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0176/-

LFCtreatmentdescriptionclass of inhibitor

-1.026

Amikacinug/mL Amikacintranslation

-0.182

Cap5-10ug/mL Capreomycintranslation

-0.845

Rox10-50 ug/mL Roxithromycintranslation

-0.491

SM2-5 ug/mL Streptomycintranslation

-1.060

Tet5-10 ug/mL Tetracyclinetranslation

-0.439

Rif0.2-5ug/mL Rifampicintranscription

0.351

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.047

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.738

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.114

CPZ10-50 ug/mL Chlorpromazinerespiration

0.009

Clofazimine10-13 ug/mL Clofaziminerespiration

0.692

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.019

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.416

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.572

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.554

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.020

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.454

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.851

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.357

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.369

KCN5-20 ug/mL Potassium cyaniderespiration

-0.525

NaN30.2-2 mM Sodium aziderespiration

0.277

Nigericin50 uM Nigericinrespiration

-0.469

TRC10-150 ug/mL Triclosanrespiration

-1.550

TRZ10-25 ug/mL Thioridazinerespiration

-2.205

Valinomycin0.5-10 uM Valinomycinrespiration

0.532

ZnSO42 mM ZnSO4respiration

-0.877

menadione6-10 ug/mL Menadionerespiration

-0.022

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.087

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.022

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.632

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.040

NRP_1Non-replicating persistence stage 1dosRassociated

-0.053

Amp0.2mg/mL AmpicillincellWall

0.097

Cephalexin20-100 ug/mL CephalexincellWall

0.277

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.174

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.305

EMB10-20 ug/mL EthambutolcellWall

-0.299

Eta12-40 ug/mL EthionamidecellWall

-0.229

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.115

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.317

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.477

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.482

BZA0.12 mg/mL BenzamidearomaticAmides

1.072

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.863

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.632

H2O24 mM hydrogen peroxideDNAdamaging

-0.431

Levo10 ug/mL LevofloxacinDNAdamaging

0.635

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.958

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.601

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.505

UVUV-irradiationDNAdamaging

-0.629

ARP41-4 ug/mL Antitubercular compound ARP4?

0.536

Antimycin12.5-50 ug/mL Antimycin A?

0.502

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.468

PA_110-50 ug/mL Antitubercular compound PA-1?

0.674

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.598

PA8240.2-2 ug/mL PA-824?

-0.889

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.141

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.428

Verapamil50 uM Verapamil?

0.354

mercaptoethanol2 mM 2-Mercaptoethanol?

0.657

methoxatin10-20 ug/mL Methoxatin?